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Abstract
Background/objective: The number of long-term survivors of childhood acute leukemia 
(AL) is substantially growing. These patients are at high risk for metabolic syndrome (MS), 
especially those who received total body irradiation (TBI). The consequences of children’s 
irradiation on adipose tissue (AT) development in adulthood are currently unknown.  
The objective of this study is to assess the impact of TBI on AT of childhood AL survivors.
Design: We compared the morphological and functional characteristics of AT among 
survivors of childhood AL who developed MS and received (n = 12) or not received 
(n = 12) TBI.
Subjects/methods: Body fat distribution and ectopic fat stores (abdominal visceral and 
liver fat) were evaluated by DEXA, MRI and 1H-spectroscopy. Functional characteristics 
of subcutaneous AT were investigated by studying gene expression and pre-adipocyte 
differentiation in culture.
Results: Patients who have received TBI exhibited a lower BMI (minus 5 kg/m2) and a 
lower waist circumference (minus 14 cm), especially irradiated women. Despite the  
lower quantity of intra-abdominal AT, irradiated patient displayed a nearly two-
fold greater content of liver fat when compared to non-irradiated patient (17 vs 
9%, P = 0.008). These lipodystrophic-like features are supplemented by molecular 
abnormalities in subcutaneous AT of irradiated patients: decrease of gene expression  
of SREBP1 (minus 39%, P = 0.01) and CIDEA (minus 36%, P = 0.004) and a clear alteration of 
pre-adipocyte differentiation.
Conclusions: These results strongly support the direct effect of irradiation on AT, especially 
in women, leading to specific nonalcoholic fatty liver disease, despite lower BMI. A long-
term appropriate follow-up is necessary for these patients.
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Introduction
Advances in the treatment strategies and supportive care 
for childhood acute leukemia (AL) have resulted in marked 
improvements in survival, which now exceeds 80% for 
lymphoblastic and 60% for myeloid AL (1). However, 
long-term survivors of childhood AL are at increased risk 
of later in life complications (2, 3); cardiovascular disease 
(CVD) is a leading cause of mortality for these patients 
(2). In a cohort of 10,397 survivors of childhood cancer, 
the relative risk of having coronary artery disease was 
10.4 times higher than for their siblings (2). Metabolic 
syndrome (MS), a major risk factor for premature CVD and 
type-2 diabetes mellitus (4), is a common complication in 
this population (5, 6). We have already shown the high 
prevalence of MS in young adults surviving AL in the 
LEA cohort (‘Leucémie de l’Enfant et de l’Adolescent’): 
i.e., 9.2% at a mean age of 21 years (6).
Various factors contribute to metabolic abnormalities 
after AL treatment: growth hormone deficiency (7), 
chronic inflammation (8), nutritional deficiencies, gut 
microbiome, endothelial dysfunction (9) and irradiation 
(6, 10, 11, 12). Several studies have demonstrated that 
total body irradiation (TBI), given as a conditioning 
regimen before hematopoietic stem-cell transplantation, 
represents a major risk factor for developing MS and CVD 
(10, 11, 12, 13, 14, 15).
In the LEA cohort, MS was found in 18.9% of young 
adults (mean age 21 years) who had received TBI during 
childhood (6). Interestingly, even among survivors 
with MS, patients who received TBI for AL are leaner 
than those who did not (16). We have recently shown 
in a cohort of 1025 leukemia survivors that irradiated 
patients had a particular profile of MS with significantly 
more pronounced insulin resistance parameters (higher 
triglycerides, higher plasma glucose levels and lower 
HDL-C levels) despite lower BMIs and lower waist 
circumferences when compared to controls (15).
MS is the clinico-biological expression of an insulin-
resistant state. Over the years, accumulating evidence has 
revealed that insulin resistance is the consequence of a deficit 
in the capacity of subcutaneous fat to store excess energy, 
resulting in increased accumulation of fat in undesired 
sites, a phenomenon that has been described as ectopic fat 
deposition (17). The role of this ‘limited subcutaneous AT 
expandability’ is consistent with the severe insulin-resistant 
state found in patients with lipodystrophic conditions 
(18). Given the high prevalence of MS, and despite a 
lower body weight among survivors who received TBI, we 
hypothesized that exposure to radiation leads to abnormal 
fat storage with ectopic fat deposition development 
deposition and insulin resistance. Previous work by Cousin 
et al. reported that irradiation alters the proliferation and 
differentiation capacity of adipocyte precursor cells in mice 
(19). However, the effects of radiation exposure on human 
AT are unknown. No study to date had the opportunity to 
explore the AT functionality on AT biopsy in these young 
leukemia survivors.
To assess the impact of TBI on AT, we compared 
the morphological and functional characteristics of AT 
between childhood AL survivors with MS and who had 
received, or had not received TBI treatment.
Materials and methods
Patients
All the patients described here were included in the LEA 
program, a historical multicenter and prospective cohort 
established in 2003 to evaluate the long-term health 
condition, quality of life and socioeconomic status of 
survivors of childhood leukemia (3, 20). During the LEA 
follow-up, medical check-ups were repeated biannually 
until the age of 20 years and every 4 years thereafter. Since 
2007, MS, defined, according to the NCEP-ATPIII criteria 
(4), was systematically searched for in all adults. For this 
study, the clinical data and treatments related to AL were 
obtained by reviewing each patient’s medical records. 
The following inclusion criteria were used: patients were 
(i) included in the LEA cohort, (ii) aged >18  years, (iii) 
in follow-up care in the French ‘PACA-Corse’ area, (iv) 
diagnosed with MS during the LEA follow-up and (v) had 
provided written informed consent for participation in 
this study. All patients were included between May and 
September 2015. The French National Program for Clinical 
Research and the French National Cancer Institute approved 
the LEA program. This study obtained ANSM agreement 
on February 20th, 2015 and approval from CPP SUD 
MEDITERRANEE V on April 8th, 2015 (201S-A00170-49). 
The National Clinical Trial number is 02696304.
Clinical and biological parameters
The following anthropometric data were collected: body 
weight, height, BMI, waist- and hip circumference 
(measured by the same physician). The habitus, personal or 
family history of CVD were equally collected. Dietary intake 
was evaluated by a dietician using Bilnut 7.5 Windows 
software. Physical activity was assessed by the specific 
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questionnaire: ‘Global Physical Activity Questionnaire’ 
(21). Indirect calorimetry (Quark PFT ergo, COSMED, Italy) 
was done to estimate the resting metabolic rate.
Patients underwent blood analysis after overnight 
fasting that included a lipid profile, fasting plasma 
glucose, liver-enzyme levels, plasma adipokines and 
apolipoproteins. Total plasma apoC-III and apoC-II 
levels were determined using an immuno-turbidimetric 
assay (Kamiya Biomedical Company, Seattle, WA, USA). 
A specific ELISA was used to measure serum levels of 
adiponectin (Quantikine Human Adiponectin, R&D 
Systems) and leptin (Active Human Leptin DSL Systems). 
The insulin resistance homeostasis model (HOMA-IR) was 
calculated as: fasting plasma glucose (mmol/L) × fasting 
plasma insulin (mIU/L)/22.5.
Body composition and AT distribution
Dual X-ray absorptiometry (DEXA)
Body composition was assessed using the gold-standard 
dual-energy X-ray absorptiometry (Lunar iDXA, GE 
Healthcare).
Magnetic resonance imaging
Abdominal MRI (DIXON technique, 3T-MRI, Siemens 
VERIO, slices acquisition centered at L4–L5) was conducted 
to analyze the distribution of abdominal AT, that is, 
superficial subcutaneous abdominal AT (sSAT), deep 
subcutaneous abdominal AT (dSAT), or visceral abdominal 
AT (VAT), with high replicability (22) (Supplementary 
material A, see section on supplementary data given at the 
end of this article). MRI was conducted at the Center for 
Magnetic Resonance in Biology and Medicine (CEMEREM).
Liver fat content assessment
Proton magnetic resonance spectroscopy (1H-MRS) was 
used to quantify ectopic fat deposition in the liver (23, 24). 
Patients were scanned in a head first supine position, using 
3T MRI-scanner (Siemens VERIO). A single-voxel proton 
spectroscopy sequence (PRESS; repetition time = 1000 
ms, echo time = 35 ms, number of excitations = 16, and 
bandwidth of 2000 Hz) was used to determine the molecular 
content of lipids and water. A spectroscopic voxel was 
positioned in three different orientations (axial, coronal 
and sagittal). Minimal rectangular voxel dimensions were 
20 × 15 × 15 mm3. All acquisitions were performed during 
breath holding. Due to the heterogeneity of the ectopic 
fat content in liver, the hepatic triglyceride content was 
assessed in three different locations (left and right liver 
lobes and the hepatic dome) (25). Two single scan spectra 
(calculation of water saturation) and two 16-scan spectra 
were acquired. We observed in each tissue the water 
spectrum resonance at 4.7 ppm and the lipid resonance 
(CH2 of triglycerides (TG)) at 1.3 ppm. Spectra analyses 
were performed using AMARES (MRUI package) under 
an Interactive Data Language environment. The liver TG 
content was expressed as a relative percentage of water 
signal (% TG = amplitude of TG peak in 16 scans spectrum/
amplitude of water peak in single scan spectrum × 100). 
Using results of the three different areas in liver, we 
calculated the mean hepatic TG content.
Abdominal subcutaneous AT biopsy
A needle aspiration of abdominal sSAT was performed 
under local anesthesia. AT samples (200–1000 mg) were 
obtained and washed in physiological saline. A portion 
of each biopsy was placed immediately in liquid nitrogen 
and stored at −80°C until analysis. Another portion 
was placed in phosphate-buffered saline (PBS) for flow 
cytometry and cell culture.
Sample preparation and real-time PCR
Total RNA was extracted by needle aspiration from sSAT or 
from culture using the RNAeasy Lipid Mini kit (Qiagen), 
according to the manufacturer’s recommendations. RNA 
concentration and quality was confirmed using nanodrop 
(Nd-100, Nanodrop Technologies). cDNA was synthesized 
from 500 ng of total RNA. Real-time quantitative PCR 
assays were performed with Sybr green mixes using a 
thermocycler stratagem Mx3005. We used 18S rRNA as 
a normalization control. Gene expression changes were 
evaluated using the LIVAK method (26). Primer designs 
can be provided on request. For the differentiation 
markers in culture, real-time PCR assays were run on a 
StepOne detection system (Life Technologies/Applied 
Biosystem), and relative gene expression was calculated 
using the delta-cycle threshold method and normalized 
to PUM expression.
Flow cytometry
Samples of sSAT were stored in PBS at room temperature 
and sent to the STROMALab institute in Toulouse on 
the same day. Stroma-vascular fraction and mature 
adipocytes were separated as previously described (27). 
Stroma-vascular fraction cells were incubated with PBS 
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supplemented with FcR Block reagent (MiltenyiBiotec). 
Staining was performed by incubating cells for 30 min at 
4°C with conjugated primary antibodies or an appropriate 
immunoglobulin G isotype control (BD Biosciences). DAPI 
was used for the viability control. Cells were analyzed on 
a FACS Canto II flow cytometer (BD Biosciences). Data 
acquisition was performed with FACS Diva software 
and analysis was performed with Kaluza software 
(Beckman-Coulter). Pre-adipocyte cells were characterized 
as CD34+/CD45−/CD31−.
Pre-adipocyte culture
The stroma-vascular fraction was isolated from human sSAT 
obtained from 14 samples, as previously described (27, 28). 
Briefly, the stroma-vascular fraction was formed by plating 
overnight in DMEM medium supplemented with 10% 
newborn calf serum, 250 µg/mL amphotericin, 5 µg/mL 
streptomycin and 5 U/mL penicillin. After 24 h, the cultures 
were washed extensively using PBS to remove residual non-
adherent cells. Cells were incubated at 37°C under 5% 
CO2, and the medium was changed twice weekly. Cultures 
were pursued until cells reached 75% confluence. Adipose 
differentiation was then induced by adding dexamethasone 
(1 µM), indomethacin (60 µM), isobutyl-methyl xanthine 
(IBMX, 450 µM), insulin (5 µg/mL) and rosiglitazone (2 µM) 
for 3 days. The medium was then replaced with the same 
supplementation medium without IBMX for four additional 
days. Adipogenic differentiation was evaluated by 
quantification of the expression of differentiation markers. 
Adipocytes were quantified by counting the number of 
lipid-loaded cells under the microscope (Nikon, TE2000S) 
in randomized sections of the culture plates.
Statistical analysis
All statistical analyses were performed using Prism 
software (GraphPad software 6.0). Values are expressed as 
mean ± standard deviation (s.d.). The Gaussian distribution 
of all parameters was tested and parametric (unpaired 
Student’s t-test) or nonparametric tests (Mann–Whitney 
test) were selected, as appropriate. Fisher’s exact test was 
used for non-continuous variables. Statistical significance 
was defined as P < 0.05.
Results
Patients characteristics
Among the 409 adult patients included in the LEA cohort 
and followed in the French area ‘PACA-Corse’, 337 patients 
were screened for MS. Of these 337 patients, 37 had been 
diagnosed with MS during the LEA follow-up and fulfilled 
all the inclusion criteria, of which 24 agreed to participate 
in the study (flow chart in Supplementary Table A). Twelve 
patients who had received TBI as a conditioning regimen 
before hematopoietic stem-cell transplantation for AL were 
included in the ‘TBI group’. The 12 other patients who 
received chemotherapy alone (i.e. without TBI) were included 
in the ‘no-TBI group’. Patients characteristics at the time of 
leukemia are summarized in Table  1 and more details on 
leukemia treatment are available in Supplementary Table B.
For all 24 patients, the diagnosis of MS was made 
during the LEA follow-up. The mean age at MS diagnosis 
was 29.0 ± 8.4 years in the TBI group vs 27.3 ± 6.5 years in 
the no-TBI group (NS). From MS diagnosis until inclusion 
in the present study, some patients changed their lifestyle 
and dietary habits. At the time of inclusion, nine patients 
still fulfilled three or more criteria for MS (4/12 in the 
no-TBI group and 5/12 in the TBI group).
Patients characteristics at inclusion, according to TBI 
treatment, are summarized in Table  2. The gender ratio 
(M/F) was respectively 1.4 in the no-TBI group and 0.5 
in the TBI group. Mean age of patients at inclusion was 
31.1 years in the no-TBI group and 32.9 years in the TBI 
group (NS). One male in the TBI group experienced a 
coronary event at the age of 30 years. Blood pressure was 
not different between groups.
Apolipoprotein CII and NEFA levels were increased in 
the TBI group compared to the no-TBI group (respectively 
54 vs 33 mg/L, P = 0.05 and 0.6 vs 0.4 mmol/L, P = 0.05). 
Triglycerides and Apolipoprotein CIII levels tended to 
be higher in the TBI group without reaching statistical 
significance. At inclusion, there was no difference in 
the glucose parameters between the TBI and the no-TBI 
groups. Five patients were diagnosed with type-2 diabetes 
(three from the TBI group and two from the no-TBI group).
The hormonal status of each patient was evaluated at 
inclusion. Six patients from the TBI group and one from 
the no-TBI group had a history of hypothyroidism, which 
was corrected with thyroid hormone. No patient had a 
growth-hormone deficiency. Three patients in the TBI 
group presented with hypogonadism at inclusion (two 
men, one woman). Hormonal data according to group 
and gender are reported in Supplementary Table C.
Irradiated women are leaner with less  
intra-abdominal fat compared to no-TBI group
Among patients who developed MS, those who received 
TBI were significantly smaller and thinner than the 
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no-TBI group (15, 16) (Table 3). Mean BMI decreased by 
five points in the TBI group (25 vs 30 kg/m2, P = 0.06). 
This difference was more pronounced in women, known 
to develop more AT than men (mean BMI in TBI women 
at 26 vs 34 kg/m2 in no-TBI women, P = 0.03). After 
irradiation, waist and hip circumferences were ~10 cm 
and 20 cm lower in men (NS) and women (P = 0.02), 
respectively. Gynoid and android fat masses, evaluated 
by DEXA were significantly decreased in women from 
the TBI group vs no-TBI (respectively, P = 0.02 and 
P = 0.045) (Table 3). Consistent with these data, there was 
a significant decrease in plasma-leptin levels in women 
from the TBI group (32 vs 53 ng/mL, P = 0.045) (Table 3). 
Adiponectin concentrations were decreased in irradiated 
men (1.0 vs 2.5 μg/mL, P = 0.04).
In order to distinguish peripheral and intra-abdominal 
AT accumulation in MS patients, we performed abdominal 
MRIs in the two groups. Twenty-two patients could have 
an MRI, but one patient presented with a contraindication 
and another refused the MRI. Intra-abdominal AT was 
significantly decreased in women within the TBI group 
(228 vs 373 cm2, P = 0.02) (Table  4). Other measures 
of AT (total AT surface as well as other specific AT 
sub-compartments: superficial compartmentalization: 
sSAT, that is, peripheral and deep intra-abdominal 
AT (dSAT and VAT) (29)) tended to decrease in both 
genders within the TBI group but without reaching the 
statistical significance.
Nutritional assessment and physical activity 
of the patients are described in Supplementary 
Table  D. No difference was found between the 
two groups except for a decrease in resting energy 
expenditure in the TBI group in agreement with the 
thinner phenotype.
Table 1 Patients medical history.
No-TBI (n = 12) TBI (n = 12) P
Characteristics of leukemia history
 Age at AL diagnosis (years, mean ± s.d.) 9.9 ± 4.3 6.8 ± 4.5 0.1
 Leukemia type, n
  ALL 7 10 0.37
  AML 5 2
 BMI at AL diagnosis (Z-score, mean ± s.d.) 0.7 ± 3.3 0.5 ± 1.0 0.31
 BMI at AL diagnosis (kg/m2, mean ± s.d.) 19 ± 8 17 ± 2 0.62
 Time from AL diagnosis to last LEA visit (years, mean ± s.d.) 18.4 ± 8.7 23.8 ± 6.8 0.1
AL, acute leukemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; BMI, body mass index (weight/height2); TBI, total body irradiation
Table 2 Patients characteristics at inclusion in the present study (n = 24).
No-TBI (n = 12) TBI (n = 12) P
Demographic characteristics
 Age (years, mean ± s.d.) 31.1 ± 7.1 32.9 ± 8.2 0.57
 Gender ratio (M/F) 1.4 0.5 0.41
Cardiovascular characteristics
 Smoking, n 6 1 0.07
 Diabetes, n 2 3 1
 Cardiovascular disease, n 0 1 1
 Systolic blood pressure (mmHg, mean ± s.d.) 120 ± 11 117 ± 10 0.43
 Diastolic blood pressure (mmHg, mean ± s.d.) 70 ± 12 70 ± 10 0.97
Lipid parameters
 Triglycerides (mmol/L, mean ± s.d.) 1.5 ± 0.7 2.1 ± 0.9 0.18
 Apolipoprotein CII (mg/L, mean ± s.d.) 33 ± 15 54 ± 27 0.05
 Apolipoprotein CIII (mg/L, mean ± s.d.) 105 ± 39 130 ± 40 0.10
 NEFA (mmol/L, mean ± s.d.) 0.4 ± 0.2 0.6 ± 0.2 0.05
 HDL-C (mmol/L, mean ± s.d.) 1.1 ± 0.2 1.0 ± 0.3 0.63
Glucose parameters
 Fasting glucose (mmol/L, mean ± s.d.) 5.4 ± 0.9 5.5 ± 1.3 0.95
 Fasting insulin (mIU/L, mean ± s.d.) 22 ± 15 25 ± 13 0.55
 HOMA-IR (mean ± s.d.) 5.6 ± 4.6 6.4 ± 3.8 0.68
AL, acute leukemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; BMI, body mass index (weight/height2); HDL-C, high-density 
lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin resistance ((glucose × insulin)/22.5); NEFA, non-esterified fatty acid; TBI, total 
body irradiation. Bold indicates statistical significance.
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Liver steatosis increased in the group of 
irradiated patients
Since we have previously shown that irradiated patients 
have an increased insulin resistance despite lower body 
weight (15), we then studied liver steatosis, a characteristic 
feature of insulin resistance state and lipodystrophic 
syndromes. The mean liver fat content in the TBI group 
was almost two times greater (17 vs 9%, P = 0.008) (Fig. 1). 
When we studied independently women and men, 
hepatic triglyceride content was increased in both sex in 
the TBI group, but the difference did not reach statistical 
significance: respectively 17 vs 8% (P = 0.06) in women 
and 16 vs 10% (P = 0.17) in men. Accordingly, gamma GT 
enzymes were increased in the TBI compared to the no-TBI 
group (59 vs 40 IU/mL, P = 0.045). Liver transaminases 
levels were unchanged between TBI and no-TBI 
groups (respectively 39 vs 28 IU/L, P = 0.18 for AST, 
Table 3 Anthropometric data and body composition of patients.
Women Men All patients
No-TBI (n = 5) TBI (n = 8) P No-TBI (n = 7) TBI (n = 4) P No-TBI (n = 12) TBI (n = 12) P
Weight (kg, 
mean ± s.d.)
86 ± 25 63 ± 20 0.04 84 ± 21 68 ± 17 0.53 85 ± 22 65 ± 19 0.02
Height (cm, 
mean ± s.d.)
159 ± 7 156 ± 6 0.51 175 ± 5 167 ± 12 0.30 168 ± 10 159 ± 10 0.03
BMI (kg/m2, 
mean ± s.d.)
34 ± 7 26 ± 7 0.03 28 ± 8 24 ± 3 0.32 30 ± 8 25 ± 6 0.06
Waist 
circumference 
(cm, mean ± s.d.)
112 ± 14 90 ± 14 0.02 98 ± 20 90 ± 11 0.65 104 ± 18 90 ± 13 0.04
Hip circumference 
(cm, mean ± s.d.)
113 ± 19 92 ± 13 0.02 97 ± 16 87 ± 10 0.44 104 ± 18 90 ± 12 0.03
Total fat mass (%, 
mean ± s.d.)
49 ± 5 41 ± 7 0.065 32 ± 10 33 ± 9 0.78 39 ± 12 38 ± 8 0.84
Lean mass (%, 
mean ± s.d.)
48 ± 5 56 ± 6 0.045 64 ± 9 64 ± 8 0.72 58 ± 11 58 ± 8 0.87
Gynoid fat mass 
(%, mean ± s.d.)
54 ± 7 42 ± 7 0.02 32 ± 12 34 ± 11 0.92 41 ± 15 39 ± 9 0.71
Android fat mass 
(%, mean ± s.d.)
57 ± 4 48 ± 8 0.045 42 ± 14 41 ± 8 0.92 48 ± 13 45 ± 8 0.53
Fat mass/height 
(mean ± s.d.)
31 ± 3 26 ± 3 0.045 19 ± 6 20 ± 4 0.53 24 ± 8 24 ± 5 0.86
Adiponectin (µg/
mL, mean ± s.d.)
4.2 ± 2.6 2.8 ± 1.9 0.30 2.5 ± 1.7 1.0 ± 0.2 0.04 3.2 ± 2.2 2.2 ± 1.7 0.13
Leptin (ng/mL, 
mean ± s.d.)
53 ± 10 32 ± 15 0.045 16 ± 16 12 ± 11 0.48 31 ± 23 25 ± 17 0.51
BMI, body mass index (weight/height2); TBI, total body irradiation. Bold indicates statistical significance.
Table 4 Abdominal fat distribution using MRI.
Women Men All patients
No-TBI (n = 5) TBI (n = 7) P No-TBI (n = 6) TBI (n = 4) P No-TBI (n = 11) TBI (n = 11) P
TAT (cm2, 
mean ± s.d.)
638 ± 191 424 ± 203 0.07 338 ± 114 318 ± 134 0.61 474 ± 214 385 ± 181 0.21
VAT (cm2, 
mean ± s.d.)
119 ± 36 87 ± 23 0.11 115 ± 40 105 ± 50 0.76 117 ± 36 94 ± 34 0.14
Intra-abdominal AT 
(cm2, mean ± s.d.)
373 ± 114 228 ± 108 0.02 232 ± 73 207 ± 74 0.47 296 ± 115 221 ± 93 0.06
SAT (cm2, 
mean ± s.d.)
519 ± 167 336 ± 204 0.11 223 ± 79 213 ± 86 0.76 358 ± 195 291 ± 177 0.47
dSAT (cm2, 
mean ± s.d.)
254 ± 86 141 ± 111 0.07 118 ± 38 102 ± 25 0.91 179 ± 93 127 ± 89 0.12
sSAT (cm2, 
mean ± s.d.)
265 ± 94 196 ± 96 0.15 106 ± 42 111 ± 62 0.76 178 ± 107 165 ± 92 0.79
AT, adipose tissue; intra-abdominal AT = dSAT+VAT; dSAT, deep SAT; SAT, subcutaneous adipose tissue; sSAT, superficial SAT; TAT, total AT; TBI, total body 
irradiation; VAT, visceral AT. Bold indicates statistical significance.
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and 46 vs 33 IU/L, P = 0.19 for ALT). Two patients had 
regular alcohol consumption (respectively 6 and 8 g/day) 
and one patient had festive consumption in the no-TBI 
group; none in the TBI group reported drinking. The 
more pronounced liver steatosis was observed in the TBI 
group despite lower intra-abdominal fat. This discordance 
was illustrated by the ratio of the mean liver fat content 
related to intra-abdominal AT that was more than two 
times higher after TBI (0.08 vs 0.03, P = 0.02).
Defect in fat storage and adipocyte differentiation in 
SAT of irradiated patients
We performed needle aspiration of sSCAT in 22 patients 
in order to analyze the gene expression of several 
proteins involved in AT homeostasis and for the study 
of pre-adipocyte differentiation in culture. Analysis of 
gene expression in sSAT revealed a decreased expression 
of genes involved in uptake and fatty acid biosynthesis, 
and in insulin sensitivity, in the TBI group: that is, 
39% decrease for SREBP-1c gene expression (P = 0.01) 
and 36% decrease for CIDEA gene expression (P = 0.004). 
Adiponectin and PPAR-γ gene expression tended to 
decrease (18% decrease for adiponectin (P = 0.08) and 
18% decrease for PPAR-γ (P = 0.11)). In addition, mRNA 
level of collagen 1a1 was 36% lower in the TBI group 
(P = 0.03). No significant difference was found for the AT 
inflammatory parameters (Fig. 2).
Pre-adipocytes number in sSAT evaluated by flow 
cytometry and expressed in cell number/g of AT did not 
differ between the two groups of patients (Fig. 3A). The 
adipogenic differentiation was then assessed by counting 
mature adipocytes and performing RT-qPCR on cell culture 
after 7 days of differentiation. As shown in Fig.  3B and 
C, the number of mature adipocytes tended to decrease 
in the TBI group (261 ± 197 vs 173 ± 89 adipocytes/mm3 
in no-TBI and TBI groups respectively, NS). As expected, 
adipocyte differentiation induced increased expression 
of PPAR-γ, aP2, leptin, LPL and GPDH in both groups. 
However, the induced expression of most of these genes 
was 2–4 times lower in differentiated cells belonging to the 
TBI group compared to no-TBI (P = 0.04 for all), indicating 
that the extent of adipocyte differentiation was reduced 
following TBI (Fig. 3D).
Discussion
To our knowledge, this is the first study which evaluates 
the impact of irradiation on AT in survivors of childhood 
AL. We have shown that patients who received TBI during 
childhood and who developed MS in adulthood have 
nearly two times more liver fat than AL survivors who 
developed MS but did not received irradiation. These 
differences were observed although irradiated patients 
had less body fat. This lower AT mass development 
is supported at the molecular level by lower gene 
expression of proteins involved in fatty acid metabolism 
and fat storage associated to a profound alteration of 
pre-adipocyte differentiation.
Thus, we first have confirmed that patients who 
underwent irradiation were more prone to metabolic 
abnormalities despite the lower BMI and lower waist 
circumference (16). However, waist circumference, which 
is correlated with visceral AT in the general population, 
is one of the five criteria used to define MS in the 
classical NCEP-ATP-III definition (4). Thus, in this specific 
population of irradiated patients, the measurement of 
waist circumference is not accurate when defining MS. 
These data highlight the need for clinicians to search for 
metabolic disorders in all patients who had TBI during 
childhood, even when the patient’s BMI and waist 
circumference are within normal range.
Liver fat is strongly correlated with insulin resistance, 
type-2 diabetes and CVD (30). An important result of this 
study is the nearly two-fold increase in liver fat found 
in the TBI group. Other studies have also reported an 
increase in liver steatosis in survivors of pediatric cancers 
after irradiation (12, 31, 32). Epidemiological studies 
have consistently demonstrated a strong association 
between VAT and hepatic triglyceride content (30). 
However, we found a higher rate of liver steatosis after 
TBI, despite lower abdominal AT (significantly decreased 
Figure 1
Liver fat content. Hepatic triglyceride content was measured by  
proton magnetic resonance spectroscopy (1H-MRS) using three voxels 
for each patient (left, right liver lobes and hepatic dome) for women, 
men and all patients in no-TBI group (white circles) and TBI group  
(black circles). **P < 0.01.
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in women). In accordance with our results, a recent study 
on nonhuman primates showed a significant reduction in 
VAT associated with a higher rate of liver steatosis after 
radiation exposure (33). We hypothesize that irradiation 
could alter the capacity of visceral adipocytes to undergo 
hyperplasia and/or differentiation, thus explaining 
this particular feature of high liver fat despite low VAT. 
Numerous recent studies have demonstrated that ectopic 
fat deposits are secondary to the relative inability of 
SAT to properly store energy and expand when there 
is a positive energy balance (34). In lipodystrophic 
syndromes, impairment in the ability of SAT to properly 
Figure 2
Impact of TBI on total subcutaneous adipose tissue. Gene expression levels involved in inflammation, fibrosis and lipogenesis between the no-TBI group 
(white bars) (n = 10) and the TBI group (black bars) (n = 10). ANGPTL2, angiopoietin like 2; CD, cluster of differentiation; CIDEA, cell death-inducing DNA 
fragmentation factor alpha-like effector A; COL, collagen; DGAT2, diacylglycerol O-acyltransferase 2; HIF, hypoxia inducible factor; IL, interleukin; MCP1, 
monocyte chemoattractant protein-1; MMP, matrix metallopeptidase; PPAR, peroxisome proliferator-activated receptor; SREBP1c, sterol regulatory 
element-binding protein 1; TBI, total body irradiation; TIMP, tissue inhibitor of metalloproteinases; TGF, transforming growth factor.
Figure 3
Differentiation of pre-adipocytes in culture. (A) Flow cytometry was performed to compare the number of pre-adipocyte cells/g of total SAT in the 
stromal-vascular fraction from the no-TBI group (black circles) (n = 6) and the TBI group (black squares) (n = 6). (B) Picture of pre-adipocytes culture after 
7 days of differentiation in no-TBI group (up) and TBI group (down). (C) Comparison of the number of adipocytes/mm3 after 7 days of differentiation.  
(D) Expression levels of genes involved in adipocyte differentiation in patients who received TBI (n = 8) or not (n = 7). Cultured pre-adipocytes were studied 
before (D0) (white bars) and at 7 days (D7) (gray bars) of differentiation. *P < 0.05. aP2, adipocyte protein 2; GPDH, glycerol-3-phosphate dehydrogenase; 
LPL, lipoprotein lipase; PPAR, peroxisome proliferator-activated receptor.
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expand leads to ectopic fat accumulation with insulin 
resistance and to fatty liver (18). Accordingly, in a recent 
4-year longitudinal study, the authors demonstrated that 
large areas of SAT at baseline seemed to be protective 
against NAFLD (nonalcoholic fatty liver disease) (35). 
Similarly, we observed a significantly higher rate of liver 
steatosis associated with a lower BMI, and a trend toward 
decreased TAT and SAT after TBI in patients who had 
been irradiated. All these observations are in favor of an 
inability of AT to properly expand after irradiation. It 
is important to note that one patient in the TBI group 
was diagnosed with hepatic fibrosis during the follow-up 
period, as a consequence of liver steatosis (diagnosed with 
a fibroscan). We demonstrate here that the screening for 
metabolic disorders and NAFLD in patients who received 
TBI in childhood is essential for their long time follow-up.
When we studied the functional aspects of SAT in 
the long-term AL survivors after irradiation, we found 
a significantly reduced gene expression of CIDEA and 
SREBP1c, which are involved in the uptake and biosynthesis 
of fatty acids and play an important role in metabolic 
homeostasis. Indeed CIDEA level in white AT is positively 
correlated with expandability of SAT, insulin sensitivity 
and healthy obesity in mice (36). SREBP1c is an important 
pro-adipogenic transcription factor that directly regulates 
the expression of several key genes in lipid metabolism 
and also regulates adipogenesis (37). The reduced gene 
expression of CIDEA and SREBP1c in SAT observed 
after irradiation could explain the incapacity of SAT to 
properly expand, leading to ectopic fat accumulation. 
Moreover, our results show that the differentiation 
capacity of adipocyte precursor cells was altered in the 
SAT of irradiated patients, with a clear reduction in the 
expression levels of several key genes involved in pre-
adipocyte differentiation and lipid accumulation. This 
lower extent of adipose differentiation following TBI was 
consistent with a slightly reduced adipocyte number in 
culture in the TBI group compared to the no-TBI one. 
These results were also consistent with the significant 
decrease in the proliferation and differentiation capacity 
of pre-adipocytes following irradiation in mice (19). 
It would have been informative to measure adipocyte 
size in these patients. Unfortunately, the AT samples we 
obtained by needle aspiration were too disrupted to allow 
a proper histological analysis. This minimally invasive 
technique was used instead of the biopsy for ethical 
reasons because patients have usually already undergone 
many invasive treatments.
We did not find any difference between groups 
regarding local inflammation in SAT. This is in agreement 
with the fact that liver steatosis and insulin resistance 
are not related to AT inflammation in lipodystrophic 
syndromes (38). Altogether, these results support the 
direct effect of irradiation on AT, leading to alteration 
in pre-adipocyte differentiation and AT fat storage, thus 
causing increased TG accumulation within the liver.
Our data on irradiated patients were particularly clear 
for women known to develop more AT than men. Indeed, 
the differences in BMI and waist circumference between 
the two groups were more pronounced for women and 
a decrease in fat mass and intra-abdominal fat was only 
observed in women. Other studies have also reported that 
girls are more prone to having a lower BMI after irradiation 
(32, 39). Further studies are needed to explore the reasons 
for a higher susceptibility to irradiation in women.
Several other factors are involved in the greater risk 
of developing MS and CVD, specifically after irradiation. 
TBI is associated with a high risk of developing 
endocrine disorders at the time of treatment and later 
on: i.e., growth-hormone deficiency, hypothyroidism 
and gonadic dysfunction (39). In the present study, 
no growth-hormone deficiency, which is frequently 
associated with insulin resistance, was diagnosed at 
inclusion. Despite being within the normal range, thyroid 
levels did statistically differ between the two groups; 
however, this difference is unlikely to have caused insulin 
resistance. Three patients in the TBI group presented with 
hypogonadism at inclusion. Hypogonadism could lead to 
insulin resistance but few data show a link between low 
levels of testosterone and liver steatosis (40). Regarding 
other risk factors for MS, our previous study (41) did not 
find any correlation between the use of steroid for AL 
treatment and MS in irradiated patients. An increased BMI 
at the time of AL diagnosis has been proposed as a risk 
factor for developing MS in TBI patients (6), but we did 
not find any difference in the BMIs of the two groups (at 
the time of AL).
Conclusion
In conclusion, long-term survivors of childhood AL 
who received TBI treatment may present features of 
lipodystrophy, even decades later. Thus, long-term 
appropriate follow-up is necessary for these patients. 
NAFLD should be detected in all patients after TBI. 
Clinicians should continue to provide screening and 
preventive care for MS and CVD to irradiated patients, 
even though they have a normal waist circumference 
and BMI.
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